Lin Liang

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5-Mediated Glutamine Metabolism Through YY1.

CD90 Promotes Gastric Cancer Progression by Regulating SLC1A5-Mediated Glutamine Metabolism Through YY1.

Journal: Cancer science

Published: November 20, 2025

CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis.

CD90 mediates gastric cancer immune evasion though regulating IGF2BP2 to stabilize the m6A-CD47/SIRPα axis.

Journal: Cancer cell international

Published: October 26, 2025

Chemotherapy-induced senescent nasopharyngeal carcinoma cells suppress NK cell-mediated antitumor immunity by upregulating EBI3 via mtDNA-cGAS-STING pathway.

Chemotherapy-induced senescent nasopharyngeal carcinoma cells suppress NK cell-mediated antitumor immunity by upregulating EBI3 via mtDNA-cGAS-STING pathway.

Journal: Cell communication and signaling : CCS

Published: September 18, 2025

Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression.

Inhibin beta A drives colorectal cancer progression through macrophage M2 polarization and mitochondria-dependent ferroptosis suppression.

Journal: Signal transduction and targeted therapy

Published: May 09, 2025

CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein.

CD38 inhibits ferroptosis to promote radiotherapy resistance in nasopharyngeal carcinoma by competitively binding to TRIM21 to stabilize SLC7A11 protein.

Journal: International journal of biological macromolecules

Published: March 17, 2025

The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome.

The immune-related prognostic gene AIM2 promotes pancreatic cancer progression via inflammasome.

Journal: Scientific reports

Published: January 10, 2025

Progress on multifunctional transmembrane protein ATG9A.

Progress on multifunctional transmembrane protein ATG9A.

Journal: Cell communication and signaling : CCS

Published: December 06, 2024

How is patient trust transferred from online medical platforms to offline?

How is patient trust transferred from online medical platforms to offline?

Journal: Frontiers in public health

Published: November 27, 2024

CD38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8+T cell-mediated anti-tumor immunity.

CD38 degrades MAVS through mitophagy to inhibit type I interferon secretion in nasopharyngeal carcinoma cells and impairs CD8+T cell-mediated anti-tumor immunity.

Journal: Nature communications

Published: October 14, 2024

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells.

Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cells.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: July 31, 2024

CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 axis.

CD38 symmetric dimethyl site R58 promotes malignant tumor cell immune escape by regulating the cAMP-GSK3β-PD-L1 axis.

Journal: Heliyon

Published: July 15, 2024

CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression.

CircGSK3β mediates PD-L1 transcription through miR-338-3p/PRMT5/H3K4me3 to promote breast cancer cell immune evasion and tumor progression.

Journal: Cell death discovery

Published: May 27, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026